Novo: Novo Real-world Studies Link Wegovy 2.4 Mg To Reductions In Liver Enzymes, Weight, And Blood Sugar In Adults With MASH

Semaglutide 2.4 Mg Was Also Associated With Significantly Greater Reductions Than Resmetirom In Ast & Some Cardiometabolic Measures